TROG 01.05 - Superdex/Spinal Cord Compression - TROG Cancer Research

TROG 2026 ASM: Early Bird Registration now open

TROG opens international skin cancer trial in Australia

TROG SDA Grant for emerging investigators: Apply now

Nominations close soon for TROG Annual Awards for Excellence

By w.paterson
14 August, 2021
0 Comments

A Pilot Randomised Controlled Trial of Dexamethasone 96mg Versus 16mg Per Day for Malignant Spinal Cord Compression Treated by Radiotherapy - TROG SuperDex Pilot

Primary Sponsor

Trans-Tasman Radiation Oncology Group (TROG)

Clinical Trial Registration

Registration Link

Related Post

A/Prof Hien Le addresses the 2025 TROG Concept Development Workshop

4 December, 2025

TROG Concept Development Workshop sows seeds for innovative new research

LATEST NEWS: 4 December 2025 TROG provided a kick-start

26 November, 2025

TROG Member Prof Paul Keall’s innovative research recognised in two Premier’s Awards

LATEST NEWS; 26 November 2025 Medical physics researcher and